1. Home
  2. TKNO vs HPF Comparison

TKNO vs HPF Comparison

Compare TKNO & HPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • HPF
  • Stock Information
  • Founded
  • TKNO 1996
  • HPF 2002
  • Country
  • TKNO United States
  • HPF United States
  • Employees
  • TKNO N/A
  • HPF N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • HPF Finance Companies
  • Sector
  • TKNO Health Care
  • HPF Finance
  • Exchange
  • TKNO Nasdaq
  • HPF Nasdaq
  • Market Cap
  • TKNO 256.9M
  • HPF 341.3M
  • IPO Year
  • TKNO 2021
  • HPF N/A
  • Fundamental
  • Price
  • TKNO $4.35
  • HPF $16.16
  • Analyst Decision
  • TKNO
  • HPF
  • Analyst Count
  • TKNO 0
  • HPF 0
  • Target Price
  • TKNO N/A
  • HPF N/A
  • AVG Volume (30 Days)
  • TKNO 224.0K
  • HPF 35.3K
  • Earning Date
  • TKNO 08-07-2025
  • HPF 01-01-0001
  • Dividend Yield
  • TKNO N/A
  • HPF 8.96%
  • EPS Growth
  • TKNO N/A
  • HPF N/A
  • EPS
  • TKNO N/A
  • HPF N/A
  • Revenue
  • TKNO $38,923,000.00
  • HPF N/A
  • Revenue This Year
  • TKNO $9.52
  • HPF N/A
  • Revenue Next Year
  • TKNO $15.20
  • HPF N/A
  • P/E Ratio
  • TKNO N/A
  • HPF N/A
  • Revenue Growth
  • TKNO 11.40
  • HPF N/A
  • 52 Week Low
  • TKNO $4.00
  • HPF $12.99
  • 52 Week High
  • TKNO $10.37
  • HPF $16.80
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 43.35
  • HPF 56.92
  • Support Level
  • TKNO $4.22
  • HPF $16.17
  • Resistance Level
  • TKNO $4.94
  • HPF $16.27
  • Average True Range (ATR)
  • TKNO 0.29
  • HPF 0.08
  • MACD
  • TKNO -0.00
  • HPF 0.00
  • Stochastic Oscillator
  • TKNO 16.75
  • HPF 51.23

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About HPF John Hancock Pfd Income Fund II Pfd Income Fund II

John Hancock Preferred Income Fund II is the United States based closed-end, diversified management investment company. Its primary objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. The fund's principal investment strategies include to invests a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, capital preferred securities and short-term investments.

Share on Social Networks: